Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48(Cre/+).LSL-Kras(G12D/+) mice

Documenti analoghi

• Inhibition of Pancreatic Intraepithelial Neoplasia Progression to Carcinoma by Nitric Oxide-Releasing Aspirin in p48(Cre/+)-LSL-Kras(G12D/+) Mice
  di: Rao, Chinthalapally V, et al.
  Pubblicazione: (2012)
• Endogenous n-3 Polyunsaturated Fatty Acids Delay Progression of Pancreatic Ductal Adenocarcinoma in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) Mice
  di: Mohammed, Altaf, et al.
  Pubblicazione: (2012)
• EGFR inhibitor gefitinib prevents progression of pancreatic lesions to carcinoma in a conditional LSL-Kras(G12D/+) transgenic mice model
  di: Mohammed, Altaf, et al.
  Pubblicazione: (2010)
• Loss of natural killer T cells promotes pancreatic cancer in LSL‐Kras(G12D/+) mice
  di: Janakiram, Naveena B., et al.
  Pubblicazione: (2017)
• Improved innate immune responses by Frondanol(®) A5, a sea cucumber extract, prevent intestinal tumorigenesis
  di: Janakiram, Naveena B., et al.
  Pubblicazione: (2015)